Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy

Sewanti Limaye, Barbara A. Murphy, Michael T. Brennan et al.|Cancer|2013

Cited by 126